in a retrospective study , three groups of patients with acute myeloid leukaemia were analyzed in respect to the outcome of remission induction therapy : group i ( vincristine , daunorubicin and prednisone ) was treated between 1970 and 1976 , group ii ( daunorubicin and cytosine-arabinoside ) between 1976 and 1980 and group iii ( daunorubicin , cytosine-arabinoside , 6-thioguanine and consolidation therapy with cyclophosphamide , vincristine , cytosine-arabinoside and prednisone ) between 1980 and 1982 .
C0023467
acute myeloid leukaemia
C0011015
daunorubicin